Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Lakatos

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 22, 2020
A further "stri(v)de" in IBD managementVito Annese, Peter L Lakatos
Journal of Crohn'S & Colitis|July 23, 2019
Can We Say No to the 'Nocebo Effect' in Inflammatory Bowel Diseases?Lorant Gonczi, Peter L Lakatos
Current Opinion in Gastroenterology|May 10, 2014
Serological studies in inflammatory bowel disease: how important are they?Maria Papp, Peter L Lakatos
Therapeutic Advances in Gastroenterology|October 30, 2024
Advanced combination therapy: is it the best way to break the therapeutic ceiling?Panu Wetwittayakhlang, Peter L Lakatos
Inflammatory Bowel Diseases|August 7, 2013
Reply: To PMID 23399739Peter L Lakatos, Laszlo Lakatos
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2012
Challenges in calculating the risk for colorectal cancer in patients with ulcerative colitisPeter L Lakatos, Laszlo Lakatos
Journal of Crohn'S & Colitis|June 7, 2021
Comforting Data on the Incidence of Rectal Cancer After Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters!Panu Wetwittayakhlang, Peter L Lakatos
Journal of Crohn'S & Colitis|March 18, 2024
Unravelling the Smoke Trail: Maternal Smoking, Childhood Exposure, and their Impact on Inflammatory Bowel DiseasesPanu Wetwittayakhlang, Peter L Lakatos
Journal of the Canadian Association of Gastroenterology|February 5, 2024
Current Evidence for Combined Targeted Therapy for the Treatment of Inflammatory Bowel DiseasePanu Wetwittayakhlang, Peter L Lakatos
Anticancer Research|May 4, 2005
Ribavirin in the treatment of hepatitis CMargit E Abonyi, Peter L Lakatos
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 22, 2020
A further "stri(v)de" in IBD managementVito Annese, Peter L Lakatos
Journal of Crohn'S & Colitis|July 23, 2019
Can We Say No to the 'Nocebo Effect' in Inflammatory Bowel Diseases?Lorant Gonczi, Peter L Lakatos
Current Opinion in Gastroenterology|May 10, 2014
Serological studies in inflammatory bowel disease: how important are they?Maria Papp, Peter L Lakatos
Therapeutic Advances in Gastroenterology|October 30, 2024
Advanced combination therapy: is it the best way to break the therapeutic ceiling?Panu Wetwittayakhlang, Peter L Lakatos
Inflammatory Bowel Diseases|August 7, 2013
Reply: To PMID 23399739Peter L Lakatos, Laszlo Lakatos
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2012
Challenges in calculating the risk for colorectal cancer in patients with ulcerative colitisPeter L Lakatos, Laszlo Lakatos
Journal of Crohn'S & Colitis|June 7, 2021
Comforting Data on the Incidence of Rectal Cancer After Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters!Panu Wetwittayakhlang, Peter L Lakatos
Journal of Crohn'S & Colitis|March 18, 2024
Unravelling the Smoke Trail: Maternal Smoking, Childhood Exposure, and their Impact on Inflammatory Bowel DiseasesPanu Wetwittayakhlang, Peter L Lakatos
Journal of the Canadian Association of Gastroenterology|February 5, 2024
Current Evidence for Combined Targeted Therapy for the Treatment of Inflammatory Bowel DiseasePanu Wetwittayakhlang, Peter L Lakatos
Anticancer Research|May 4, 2005
Ribavirin in the treatment of hepatitis CMargit E Abonyi, Peter L Lakatos
Pageof 22